An spokeswoman said: “As far as possible, Essity is developing robust contingency plans across the whole of our supply chain to mitigate any short-term risks following a ‘no-deal’ or ‘hard’ exit of the EU.
“However, stocks are not unlimited, and some will not withstand long-term border delays outlined by the government or in the event of consumer panic buying.”
The company manufactures tissue in the UK and said it had built stocks of raw materials and spare parts to ensure supply in the event of short-term border delays.
It is also holding stocks of finished products that are imported or exported between the UK and EU.